Do you want to read an article? Please log in or register.
Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis
Radio-Oncology
Related content
Further Publications
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis
JAMA Oncol.
Wang Y, Zhou S, Yang F, Qi X, Wang X, Guan X, Shen C, Duma N, Vera Aguilera J, Chintakuntlawar A, Price KA, Molina JR, Pagliaro LC, Halfdanarson TR, Grothey A, Markovic SN, Nowakowski GS, Ansell SM, Wang ML
doi: 10.1001/jamaoncol.2019.0393
Breast Cancer
Recent Developments in Metastatic Breast Cancer
healthbook TIMES Oncology Hematology
Skin Cancer
Systemic Therapy for Previously Untreated Advanced BRAF-Mutated Melanoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials
JAMA Oncol.
Devji T, Levine O, Neupane B, Beyene J, Xie F
doi: 10.1001/jamaoncol.2016.4877.
Further Publications
Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis
JAMA Oncol.
Duan J, Cui L, Zhao X, Bai H, Cai S, Wang G, Zhao Z, Zhao J, Chen S, Song J, Qi C, Wang Q, Huang M, Zhang Y, Huang D, Bai Y, Sun F, Lee JJ, Wang Z, Wang J
doi: 10.1001/jamaoncol.2019.5367.
Further Publications
Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis
JAMA Oncol.
Lu S, Stein JE, Rimm DL, Wang DW, Bell JM, Johnson DB, Sosman JA, Schalper KA, Anders RA, Wang H, Hoyt C, Pardoll DM, Danilova L,
Taube JM
doi: 10.1001/jamaoncol.
Further Publications
A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors
Cancer Treat Rev
Martorana F, Colombo I, Treglia G, Gillessen S, Stathis A
doi: 10.1016/j.ctrv.2021.102300
Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis
JAMA Oncol.
Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, Tolaney SM
doi: 10.1001/
RECOMMENDED
Radio-Oncology
Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy
★ 1
Recommended by
Alexander Meisel, Faculty Member
Eur J Cancer.
Schweizer C, Schubert P, Rutzner S, Eckstein M, Haderlein M, Lettmaier S, Semrau S, Gostian AO, Frey B, Gaipl US, Zhou JG, Fietkau R, Hecht M
doi: 10.1016/j.ejca.2020.09.001.Visit the original publication at ncbi.nlm.nih.gov
Skin Cancer
Risk of treatment-related mortality in cancer patients treated with ipilimumab: A systematic review and meta-analysis
Eur J Cancer.
Zhang S, Liang F, Li W, Wang Q
doi: 10.1016/j.ejca.2017.06.021.